Clinical trial
A Study of Safety and Efficacy of Ultracet in Patients With Chronic Cancer Pain
NCT01968018 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd.,Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Safety and Efficacy of Ultracet in Patients With Chronic Cancer Pain
- Lead sponsor
- Janssen-Cilag Ltd.,Thailand
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- April 30, 2007
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer